Kawano Mitsuhiro
Innovative Clinical Research Center, Department of Nephrology and Rheumatology, Kanazawa University Hospital, Japan.
Intern Med. 2025 Jan 1;64(1):31-39. doi: 10.2169/internalmedicine.3154-23. Epub 2024 Feb 19.
IgG4-related disease (IgG4-RD) is a systemic and chronic inflammatory disorder that can affect every part of the body. The formation of tertiary lymphoid tissues (TLT) in the affected organs may be a key phenomenon in understanding the pathogenesis of this disease because T follicular helper (Tfh) 2 cells play an important role in IgG4 class switching within TLT in the affected organs or tissues. TLT formation leads to the formation of masses or swelling of the affected organs. Interleukin (IL)-4 and IL-10 are critical cytokines for IgG4-class switching and are produced in TLT. Other factors, such as CD4-positive (CD4+) cytotoxic T cells, M2 macrophages, and LAG3+ Tfh cells, have been identified as disease-specific contributors to lesion formation. In this review, I describe the current knowledge necessary to understand the pathogenesis of this disease and recent developments in treatment strategies beyond B-cell depletion therapy.
IgG4相关疾病(IgG4-RD)是一种可累及身体各个部位的全身性慢性炎症性疾病。在受影响器官中三级淋巴组织(TLT)的形成可能是理解该疾病发病机制的关键现象,因为T滤泡辅助(Tfh)2细胞在受影响器官或组织的TLT内IgG4类别转换中起重要作用。TLT的形成会导致受影响器官出现肿块或肿胀。白细胞介素(IL)-4和IL-10是IgG4类别转换的关键细胞因子,并在TLT中产生。其他因素,如CD4阳性(CD4+)细胞毒性T细胞、M2巨噬细胞和LAG3+ Tfh细胞,已被确定为病变形成的疾病特异性促成因素。在这篇综述中,我描述了理解该疾病发病机制所需的当前知识以及除B细胞清除疗法之外治疗策略的最新进展。